Trusted Resources: Education
Scientific literature and patient education texts
Prenatal Diagnosis of Mucopolysaccharidoses Type II by Two-Dimensional Electrophoresis and Mass Spectrometry in Amniotic Fluid
source: The journal of obstetrics and gynaecology research
year: 2022
authors: Aboulnasr AA,Elnouri A,Abdel Sameea G,Gouda AS,Ibrahim MM,Shalabi TA,Gaber KR
summary/abstract:To introduce a quantitative determination of heparan sulfate and dermatan sulfate by mass spectrometry and to compare it with two-dimensional electrophoresis of the glycosaminoglycans in the amniotic fluid for the prenatal diagnosis of mucopolysaccharidoses type II (MPS II).
organization: Prenatal Diagnosis and Fetal Medicine Department, National Research Centre, Giza, Egypt.DOI: 10.1111/jog.15135
read more
BookmarkRelated Content
-
Denali Therapeutics Announces Continued Progress in DNL310 (ETV:IDS) Program for MPS II (Hunter Syndrome) Supporting...Denali Therapeutics Inc., a biopharmaceu...
-
iPS-Derived Neural Stem Cells for Disease Modeling and Evaluation of Therapeutics for Mucopolysaccharidosis Type IIMucopolysaccharidosis type II (MPS II), ...
-
Aiden and Aj’s Story – Living With Hunter Syndromehttps://www.youtube.com/watch?v=9rt-e3Ky...
-
Convergent Molecular Mechanisms Underlying Cognitive Impairment in Mucopolysaccharidosis Type IIMucopolysaccharidosis type II (MPS II) i...
-
Hunter and Kingston’s StoryI have three sons. Hunter is my oldest, ...
-
Joseph Muenzer, MD, PhDJoseph Muenzer, MD, PhD is a Professor i...
-
Hunting Hunter Syndrome: A Rare Disease Hidden Among Childhood Complaintshttps://www.youtube.com/watch?v=QJYy4wbV...
Powered by
